ClearPoint Neuro, Inc. CLPT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -36.14M | -34.57M | -29.07M | -25.54M | -23.14M |
| Total Depreciation and Amortization | 3.97M | 3.07M | 2.62M | 2.14M | 1.86M |
| Total Amortization of Deferred Charges | 1.17M | 850.00K | 521.00K | 182.00K | 60.00K |
| Total Other Non-Cash Items | 9.48M | 9.97M | 9.63M | 9.11M | 8.82M |
| Change in Net Operating Assets | -10.65M | -9.50M | -9.43M | -9.81M | -685.00K |
| Cash from Operations | -32.17M | -30.18M | -25.72M | -23.93M | -13.09M |
| Capital Expenditure | -1.05M | -1.11M | -984.00K | -522.00K | -736.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 1.14M | 1.14M | 1.14M | 1.14M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.00K | 30.00K | 153.00K | 615.00K | -736.00K |
| Total Debt Issued | 19.43M | 19.43M | 48.09M | 48.09M | 28.65M |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 23.55M | 1.48M | 4.08M | 3.95M | 3.74M |
| Repurchase of Common Stock | -2.19M | -2.19M | -2.54M | -1.86M | -1.75M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 78.00K | 0.00 | 0.00 |
| Cash from Financing | 40.79M | 18.72M | 49.70M | 50.18M | 30.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.71M | -11.43M | 24.13M | 26.87M | 16.83M |